SCN1A and epilepsy: The genotype or allelic frequencies of SCN1A c.A3184G polymorphism did not differ significantly in drug-resistant versus drug-responsive epilepsy patients for AG (P = 0.98, OR = 0.99, 95% CI = 0.62–1.58) or GG (P = 0.78, OR = 1.17, 95% CI = 036–3.78) [Table 6].